News & Events

All the latest news and events from PhoreMost

PhoreMost enters multi-project drug target discovery collaboration with Roche
6th September 2022

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes Cambridge, UK, 06 September 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a multi-project target discovery collaboration with Roche, one of the world's leading biotechnology companies. Under …

PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration
9th November 2020

PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration

PhoreMost and XtalPi sign AI-based pharmaceutical drug discovery collaboration agreement
8th September 2020

PhoreMost and XtalPi sign AI-based pharmaceutical drug discovery collaboration agreement

Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’
30th April 2020

Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’

PhoreMost strengthens leadership team with two key appointments
3rd February 2020

PhoreMost strengthens leadership team with two key appointments

PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
21st January 2020

PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration
7th January 2020

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

No events currently available